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Abstract
Transforming growth factor-b-activated kinase 1 (TAK1) is a member of the NF-kB pathway and regulates inflammatory
responses. We previously showed that TAK1 also regulates keratinocyte growth, differentiation, and apoptosis. However, it
is unknown whether TAK1 has any role in epithelial–mesenchymal interactions. To examine this possibility, we studied the
role of TAK1 in mouse hair follicle development and cycling as an instructive model system. By comparing keratinocyte-
specific TAK1-deficient mice (Map3k7
fl/flK5-Cre) with control mice, we found that the number of hair germs (hair follicles
precursors) in Map3k7
fl/flK5-Cre mice was significantly reduced at E15.5, and that subsequent hair follicle morphogenesis
was retarded. Next, we analyzed the role of TAK1 in the cyclic remodeling in follicles by analyzing hair cycle progression in
mice with a tamoxifen-inducible keratinocyte-specific TAK1 deficiency (Map3k7
fl/flK14-Cre-ER
T2). After active hair growth
(anagen) was induced by depilation, TAK1 was deleted by topical tamoxifen application. This resulted in significantly
retarded anagen development in TAK1-deficient mice. Deletion of TAK1 in hair follicles that were already in anagen induced
premature, apoptosis-driven hair follicle regression, along with hair follicle damage. These studies provide the first evidence
that the inflammatory mediator TAK1 regulates hair follicle induction and morphogenesis, and is required for anagen
induction and anagen maintenance.
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Introduction
The NF-kB pathway mediates innate immune or pro-inflam-
matory responses, such as signaling by Toll-like receptors (TLRs),
the IL-1 receptor (IL-1R), and tumor necrosis factor receptor
(TNFR) [1,2]. Transforming growth factor-b-activated kinase 1
(TAK1) is a member of the MAP3 kinase family [3] and an
important member of the NK-kB pathway, involved in IL-1 and
TNF-a-induced activation of NF-kB and MAP kinases [1]. Upon
ligand binding, TNF-receptor-associated factor (TRAF) 6 or
TRAF2 [4,5,6] activates TAK1, which then phosphorylates IkB
kinases (IKKs), resulting in NF-kB activation.
Because members of the NF-kB pathway are increasingly
recognized as important in the regulation of epithelial–mesenchy-
mal interaction systems, ranging from tooth development to hair
follicle induction and morphogenesis [7,8,9,10,11], we were
interested in learning whether TAK1 also played a role in the
biology of the hair follicle, a prototypic epithelial–mesenchymal
interaction system. This interest was further fueled by our
previous discovery in keratinocyte-specific TAK1-deficient mice
(Map3k7
fl/flK5-Cre) that TAK1 regulates keratinocyte growth,
differentiation, and apoptosis [12]. However, the role of TAK1 in
hair follicles has not been previously studied.
Induction and morphogenesis of the hair follicle [13] is
controlled by complex signaling networks within the skin
epithelium and between the epithelium and specialized inductive
fibroblasts in its adjacent mesenchyme [7,11]. Among these
signaling networks, the NF-kB pathway and Wnt/b-catenin
signaling provide central controls [7,8]; however, the exact
relationship between these signaling networks is not fully
understood. Binding of EdaA1 to its receptor EdaR in the embryo
is essential for the development of ectodermal appendages [14],
and mutations in these genes cause reduced or absent ectodermal
appendages [15,16,17,18,19]. Subsequently, the EdaA1/EdaR
pathway activates the downstream NF-kB pathway [20]. A recent
report showed that Wnt/b-catenin signaling lies both upstream
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e11275and downstream of the EdaR/NF-kB pathway [8]. Wnt/b-
catenin signaling within the epithelial cells is required for
activation of the Eda/EdaR/NF-kB pathway at an early stage of
hair follicle development [8], and the expression of Eda and EdaR
requires Wnt/b-catenin signaling [8]. At a later stage, mainte-
nance of Wnt signaling and elevated Wnt10a, Wnt10b, and Dkk4
expression requires the Eda/EdaR/NF-kB pathway [8].
The postnatal hair cycle in mice begins with catagen induction
around P17, followed by the first telogen. Recently, the EdaR
pathway has been shown to be involved in the hair cycle [9,21,22].
The expression of EdaA1 and EdaR increases in the anagen-
catagen phase [21]. Furthermore, EdaA1 prolongs the anagen
phase [22]. Thus, in addition to its well-established role in hair
follicle morphogenesis, the EdaR pathway is also involved in hair
cycle control.
Since TAK1 is a member of NF-kB pathway, we hypothesized
that TAK1 is involved in hair follicle morphogenesis and hair
cycle control. To explore this, we studied hair follicle development
in keratinocyte-specific TAK1-deficient (Map3k7
fl/flK5-Cre) mice
and subsequent hair follicle cycling in tamoxifen-inducible
keratinocyte-specific TAK1 deficient mice (Map3k7
fl/flK14-Cre-
ER
T2) to avoid gene-targeting in embryonic development because
this might damage the hair follicle, impairing its later capacity to
cycle. These studies provide the first evidence that TAK1 regulates
hair follicle induction, morphogenesis, and cycling.
Materials and Methods
Ethics Statement




T2 mice was approved by the Institutional
Review Board of Ehime University Graduate School of Medicine
(#I-20-13 and #NE-27-16).
Generation of keratinocyte-specific TAK1-deficient mice
(Map3k7
fl/fl K5-Cre)
TAK1 is encoded by the Map3k7 gene. The targeting construct
has been described previously [1]. We generated keratinocyte-
specific TAK1-deficient mice (Map3k7
fl/flK5-Cre) by breeding
Map3k7
fl/fl mice (C57Bl/6 background) with K5-Cre mice
(C57Bl/6 background) [23], as previously described [12].





fl/fl mice were bred with K14-Cre-ER
T2 mice (C57Bl/
6 background) [24,25] to generate Map3k7
fl/flK14-Cre-ER
T2
mice. We applied 100 mL of 4-hydroxytamoxifen (Sigma-Aldrich
Co., St. Louis, MO) in ethanol at a concentration of 1 mg/mL
topically to the dorsal skin of 8-week-old female Map3k7
fl/flK14-
Cre-ER
T2 mice for 5 consecutive days [24].
Wax depilation
The hair cycle was synchronized in the dorsal skin of 8-week-old
female mice by wax (SURGI-WAX
TM, Ardell International, Los
Angeles, CA) depilation, as described previously [26].
Histological analysis
The stages of hair follicle morphogenesis, cycling, and
dystrophic catagen were morphologically defined using dorsal
skin of the mice and the score was defined as follows.
The hair morphogenesis stage of each hair follicle in each
mouse group was evaluated as described previously [13]. At least
40 hair follicles or all hair follicles in the mice were evaluated in
each mouse group (two mice/group). The score of each hair
morphogenesis stage was defined as follows: stage 1=1, stage
2=2, stage 3=3, stage 4=4, stage 5=5, stage 6=6, stage 7=7,
and stage 8=8. Then, the rate (%) of a certain hair morphogenesis
stage in the total hair follicles and the median score in each mouse
group were determined. The score of Map3k7
fl/flK5-Cre mice was
compared with Map3k7
fl/fl mice. Statistical significance was
determined using a Mann-Whitney’s U-test. A difference of
*P,0.01 was considered statistically significant.
The hair cycle stage of each hair follicle in each mouse group
was evaluated as described previously [27]. At least 40 hair follicles
were evaluated in each mouse group (two mice/group). The score
of each hair cycle stage was defined as follows: catagen I=1,
catagen II=2, catagen III=3, catagen IV=4, catagen V=5,
catagen VI=6, catagen VII=7, catagen VIII=8, telogen =9,
anagen I=10, anagen II=11, anagen IIIa=12, anagen IIIb=13,
anagen IIIc=14, anagen IV=15, anagen V=16, and anagen
VI=17. Then, the rate (%) of a certain hair cycle stage in the total
hair follicles and the median score in each mouse group were
determined. The score of tamoxifen-treated Map3k7
fl/flK14-Cre-
ER
T2 mice was compared with the control mice. Statistical
significance was determined using a Mann-Whitney’s U-test. A
difference of *P,0.01 was considered statistically significant.
Dystrophic catagen was defined according to a previous report
[28] as early dystrophic catagen, mid dystrophic catagen, late
dystrophic catagen, and dystrophic telogen. Then, the rate (%) of a
certain hair follicle stage per total hair follicles was calculated in
each mouse group. At least 40 hair follicles were evaluated in each
mouse group (two mice/group).
Results




were generated, as previously described [12]. Map3k7
fl/fl mice
were used as controls. Histological analysis of hair follicle
development is shown in Figure 1A. Although hair germs (follicle
precursors) and dermal condensations appeared in both types of
mice at E15.5, the number of hair germs in Map3k7
fl/flK5-Cre
mice was significantly lower than that in Map3k7
fl/fl mice (Fig. 1A).
At E16.5, the hair germ further progressed into the hair peg stage
of hair follicle morphogenesis in Map3k7
fl/fl mice at the rate
expected for wild-type mice [29], while hair pegs were essentially
absent in Map3k7
fl/flK5-Cre mice. Similarly, at P1-6, postnatal
hair follicle development was severely impaired in Map3k7
fl/flK5-
Cre mice (Fig. 1A).
Hair follicle morphogenesis was quantitatively analyzed. The
morphogenesis stage and the median score of each mouse group
are shown in Fig. 1B. Hair follicle morphogenesis indicators were
significantly delayed in Map3k7
fl/flK5-Cre mice, as evident from
their lower hair morphogenesis score, compared with Map3k7
fl/fl
mice at P3 and P6 (Fig. 1B).
Generation of tamoxifen-inducible keratinocyte-specific
TAK1-deficient mice
Because germline targeting of TAK1 greatly disrupted hair
morphogenesis and, thus, precluded a meaningful analysis of
subsequent hair follicle cycling, we next used tamoxifen-inducible
keratinocyte-specific TAK1-deficient mice (Map3k7
fl/flK14-Cre-
ER
T2), in which Cre-ER
T2 was expressed in the epidermis under
the control of the K14 promoter [24]. Southern blot analysis
demonstrated efficient deletion of the floxed allele in the epidermis
of tamoxifen-treated Map3k7
fl/flK14-Cre-ER
T2 mice (Fig. 2).
TAK1 Regulates Hair Growth
PLoS ONE | www.plosone.org 2 June 2010 | Volume 5 | Issue 6 | e11275Figure 1. Impaired hair follicle morphogenesis in keratinocyte-specific TAK1-deficient mice. (A) Histological analysis of hair follicle development
from E14.5 to P6. Map3k7
fl/flK5-Cre were keratinocyte-specific TAK1-deficient mice [12]. Map3k7
fl/fl mice were used as controls. Arrows indicate hair germs or
hair pegs. Scale bar, 100 mm. (B) The hair morphogenesis stage of each hair follicle in each mouse group was evaluated as described previously [13]. Then, the
rate (%) of a certain hair morphogenesis stage in the total hair follicles (left panel) and the median score in each mouse group (right panel) were determined.
The score of Map3k7
fl/flK5-Cre mice was compared with Map3k7
fl/fl mice. Statistical significance was determined using a Mann-Whitney’s U-test. *P,0.01.
doi:10.1371/journal.pone.0011275.g001
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non-keratinocyte cells, such as Langerhans cells, melanocytes, or
fibroblasts, the band of tamoxifen-treated Map3k7
fl/flK14-Cre-
ER
T2 mice was a single-recombined band. Since, the majority of
this skin sample consists of keratinocytes, flox band of non-
keratinocyte cells may not be apparent in this blot. Ethanol-treated
Map3k7
fl/flK14-Cre-ER
T2 mice also show a minor recombination
band, presumably due to slightly leaky Cre- ER
T2 activity.
Keratinocyte-specific TAK1 deletion results in hair loss in
adolescent mice
In the first experiment, tamoxifen was simply applied to the
dorsal skin of 8 weeks old mice for 5 consecutive days. Two weeks
after the application, the tamoxifen-treated Map3k7
fl/flK14-Cre-
ER
T2 mice started to lose their hair shafts, and this process
continued for more than 4 weeks (Fig. 3). This phenotype
suggested the involvement of TAK1 in hair follicle cycling.
Keratinocyte-specific TAK1 deletion delays hair cycle
progression in adolescent mice
To further dissect the role of TAK1 in hair follicle cycling,
synchronized, active hair growth (anagen) was induced in resting
(telogen) hair follicles by wax depilation [26]. This was followed by
topical tamoxifen application to the dorsal skin, to delete TAK1
(Fig. 4A). At 2 weeks after synchronizedanageninduction, hair shaft
formation was noted in the control mice, as a macroscopic indicator
of well-advanced anagen development, while hair shaft growth was
not seen in the tamoxifen-treated Map3k7
fl/flK14-Cre-ER
T2 mice
(Fig. 4B). Histological analysis revealed that anagen progression was
severely delayed in TAK1-deleted mice at 1–3 weeks (Fig. 4C).
Quantitative hair cycle histomorphometry and hair cycle score
calculation (Fig. 5) confirmed that depilation-induced anagen
progression was severely delayed in TAK1-deleted mice at 1–3
weeks, while anagen development progressed as expected in
TAK1-competent mice. Taken together, these data suggest that
TAK1 is an important regulator of early anagen development in
telogen hair follicles, although TAK1 does not appear to be
indispensable for anagen induction.
Although leaky Cre- ER
T2 activity was noted in ethanol-treated
Map3k7
fl/flK14-Cre-ER
T2 mice (Fig. 2), there was no significant




fl/fl mice. Therefore, leaky activity of
Cre- ER
T2 seems to have a minimum effect in this experiment.
Keratinocyte-specific TAK1 deletion causes a transition
from anagen to dystrophic catagen in adolescent mice
In the third experimental setup, TAK1 was deleted only 1 week
after anagen induction (Fig. 6A). At 2 weeks after depilation, hair
regrowth was reduced in the tamoxifen-treated Map3k7
fl/flK14-
Cre-ER
T2 mice (Fig. 6B), compared with controls. Histological
analysis revealed that almost all of the hair follicles in tamoxifen-
treated Map3k7
fl/flK14-Cre-ER
T2 mice had prematurely entered
the apoptosis-driven regression stage of hair follicle cycle (i.e.,
catagen; Fig. 6C).
Interestingly, however, this accelerated catagen development
was associated with striking pigmentary signs of hair follicle
damage (dystrophy): many large, ectopically located melanin
clumps, often larger than keratinocyte nuclei, were found not only
in their normal location (i.e., the precortical hair matrix), but also
eccentrically in the hair bulb periphery and in the epithelial strand
of the involuting catagen hair follicles (Fig. 6D). Thus, TAK1
deletion induced ‘‘dystrophic catagen,’’ an indicator of major hair
follicle damage [28]. Quantitative analyses (Fig. 6E) confirmed
that most of the hair follicles in tamoxifen-treated Map3k7
fl/flK14-
Cre-ER
T2 mice were in late dystrophic catagen, while those of
controls were in anagen. These data suggest that TAK1 is essential
for maintaining a functional anagen phase.
Discussion
Here, we show by mouse genomics and targeted deletion
experiments that TAK1, a member of the NF-kB pathway that
has chiefly been recognized as a mediator of innate and adaptive
immunity [1,2,4,5,6,30], is also a key component of the molecular
machinery that controls murine hair growth. Consistent with our
previous discovery that TAK1 regulates keratinocyte growth,
Figure 2. Southern blot analysis. Genomic DNA prepared from the
ear skin of mice treated with tamoxifen solution (15 mL/ear) or ethanol
for 5 consecutive days was digested with XbaI and EcoRI. Southern blot
analysis for the deletion of the floxed Tak1 allele was performed as
described previously [1]. Cre expression resulted in excision of the
floxed allele (flox) and generated the deleted allele (D)o fMap3k7.
doi:10.1371/journal.pone.0011275.g002
Figure 3. Keratinocyte-specific TAK1 deletion results in hair
loss in adolescent mice. Tamoxifen was topically applied to the
dorsal skin of the Map3k7
fl/flK14-Cre-ER
T2 mice for 5 consecutive days to
delete TAK1. The clinical appearance of the mice 4 weeks after the
application is shown. As controls, Map3k7
fl/fl mice or Map3k7
fl/flK14-Cre-
ER
T2 mice were treated with tamoxifen or ethanol, respectively.
doi:10.1371/journal.pone.0011275.g003
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deletion of TAK1 in keratinocytes retards hair follicle induction,
morphogenesis, and anagen development, and is required for the
maintenance of normal anagen. This newly identified role of
TAK1 in hair follicle development and cycling implicates TAK1
as a novel player in complex organ remodeling events and
epithelial-mesenchymal interactions, which can be modeled by
murine hair follicles [11].
The TAK1-NF-kB pathway regulates not only immune
responses [1,30], but also epithelial function [12]. Because the
NF-kB pathway controls pro-inflammatory responses, deletion of
this pathway was expected to suppress epithelial inflammation.
Unexpectedly, however, deletion of TAK1, IKK-b, or IKK-c was
found to result in severe skin inflammation (including abscess
formation) [12,31,32,33]. Similarly, a lack of NF-kB signaling
produced by the conditional ablation of IKKc or IKKa and
IKKb in the intestinal epithelium caused severe chronic intestinal
inflammation in mice [34]. This suggests that a continuous, basal
level of NF-kB activation may be required to maintain epithelial
integrity and homeostasis and to suppress excessive skin inflam-
mation. In the current study, we add to the established role of
TAK1 in murine skin the novel function of hair growth control.
Figure 4. Keratinocyte-specific TAK1 deletion delays hair cycle progression in adolescent mice. (A) Schedule of tamoxifen application.
The hair cycle was synchronized to anagen phase by wax depilation, and tamoxifen was topically applied to the dorsal skin of Map3k7
fl/flK14-Cre-
ER
T2mice to delete TAK1. As controls, Map3k7
fl/fl mice or Map3k7
fl/flK14-Cre-ER
T2 mice were treated with tamoxifen or ethanol, respectively. (B) Clinical
appearance at the indicated time point after the depilation. At 2 weeks, hair shaft formation was noted in the control mice, while hair shaft growth
was not seen in the tamoxifen-treated Map3k7
fl/flK14-Cre-ER
T2 mice. (C) Histological analysis at the indicated time point after the depilation. Anagen
progression was severely delayed in TAK1-deleted mice at 1–3 weeks. Scale bar, 100 mm.
doi:10.1371/journal.pone.0011275.g004
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possibility that hair follicle defects in TAK1-deficient mice might
be attributed to such abnormal capacities of keratinocytes rather
than reflecting the specific function of TAK1 in hair follicle
regulation. However, clinical skin pheno types and histological
abnormalities were not apparent at birth and started to appear at
P2 in Map3k7
fl/flK5-Cre mice [12]. On the other hand, E15.5 is
the time point when the defect of hair follicle development became
apparent (Fig. 1). Therefore, the defect of hair follicle development
is primarily due to the defect of TAK1 signaling during
embryogenesis, rather than the functional defect of keratinocytes.
Recently, TAK1 binding protein (TAB) 2 has been identified as
a binding partner of EdaR-associated death domain protein
(EDARADD) using a yeast two-hybrid screening [35]. In 293 cells,
endogenous and overexpressed TAB2, TRAF6 and TAK1 were
co-immunoprecipitated with EDARADD [35]. Furthermore,
dominant negative forms of TAB2, TRAF6 and TAK1 blocked
the NF-kB activation induced by EDARADD in 293 cells[35].
Therefore, it is suggested that TAK1 is involved in hair follicle
development. However, the actual role of TAK1 in hair follicle has
not been studied before.
The coats of mice contain four major hair follicle subpopula-
tions: guard hairs, awl and auchene hairs, and zigzag hairs.
Formation of each kind of hair follicle starts at E14, E16, and E18-
P3, respectively and the regulatory mechanisms of hair follicle
development are slightly different among them [7,36]. Epidermal
NF-kB activity is first observed in the placodes of primary guard
hairs at E14.5 [36]. In the absence of NF-kB activity, downstream
events, such as maintenance of Wnt signaling and an increase of
Wnt10a, Wnt10b, and Dkk4 expression, are impaired [8] and
further placode down-growth does not occur in primary guard
hair follicles [36]. In Map3k7
fl/flK5-Cre mice, the number of hair
germs was significantly reduced at E15.5, indicating that the
development of primary guard hair follicles was greatly impaired.
Impaired development of primary guard hair follicles at E15.5 can
be explained by the absence of NF-kB activity, due to TAK1
deficiency, consistent with a model in which TAK1 is involved in
the EdaA1/EdaR/NF-kB pathway [35] (see Fig. 7). The
appearance of a few primary hair placodes might be explained
by incomplete TAK1 deletion at E15.5.
In contrast, EdaR/NF-kB activity is dispensable for the
induction of awl/auchene hair follicles, as seen in tabby, downless,
and c
IkBaDN mice, even though EdaR/NF-kB-defective, awl/
auchene hair follicles subsequently produce abnormal awl-like hair
shafts [36,37]. EdaR/NF-kB independent Wnt/b-catenin signal-
ing is required for this process [8]. Thus, the placodes that became
visible in Map3k7
fl/flK5-Cre mice at E16.5 are likely to represent
placodes of awl/auchene hair follicles. In a recent study, analyses
of Eda and EdaR homologue Troy double-mutant mice revealed
that, in addition to primary guard hair follicles, awl/auchene hair
follicles were defective in these mice [38]. This study suggested
that EdaR and Troy redundantly activate an NF-kB independent
pathway, via TRAF6, to develop awl/auchene hair follicle
placodes. Therefore, it is conceivable that placode development
Figure 5. Quantitative hair cycle analysis. Hair cycle stage of each hair follicle in each mouse group in Fig. 4 was evaluated according to our
previous report [27]. Then, the rate (%) of a certain hair cycle stage in the total hair follicles (left panel) and the median score in each mouse group
(right panel) were determined. The score of tamoxifen-treated Map3k7
fl/flK14-Cre-ER




T2 mice. Statistical significance was determined using a Mann-Whitney’s U-test. *P,0.01.
doi:10.1371/journal.pone.0011275.g005
TAK1 Regulates Hair Growth
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fl/flK5-Cre mice is controlled by this NF-kB- (and
TAK1)-independent pathway (Fig. 7).
Besides NF-kB signaling, recent studies indicate the implication
of TAK1 in multiple signaling pathways such as MAP kinases and
AP1 signaling [1,39], supporting the alternative possibility that, in
addition to the NF-kB signaling pathway, multiple signaling
pathways may be also involved in hair follicle regulation
downstream to TAK1. Although some TNF receptor family
activate JNK pathway in addition to NF-kB, Edar shows only
weak activation of JNK/AP-1 pathway [14,20]. In contrast to
Edar, Troy [40] leads to a strong activation of JNK pathway, but
weak activation of NF-kB [20,40]. Therefore, it is possible Troy/
TAK1/JNK/AP-1 pathway is involved in hair morphogenesis.
However, this point should be further clarified.
An interesting difference was observed between Map3k7
fl/flK5-
Cre mice and tabby, downless, and c
IkBaDN mice. While tabby,
downless, and c
IkBaDN mice produced abnormal awl-like hair shafts,
Map3k7
fl/flK5-Cre mice exhibited a prolonged morphogenesis
period and did not develop hair shafts, even after skin
transplantation onto normal control mice (unpublished, prelimi-
nary findings). This suggests that TAK1 deletion also affects the
morphogenesis of the secondary hair follicles.
Although numerous molecular players have been identified as
powerful regulators of hair follicle cycling, the exact molecular
machinery that drives the elusive ‘‘hair cycle clock’’ remains
unclear [29,41,42,43]. For example, IGF-1, HGF, glial-derived
neurotrophic factor, and VEGF are known to prolong the
duration of anagen, while fibroblast growth factor 5, TGFb1
and TGFb2, IL-1b, NT-3, estrogen receptor-mediated signaling,
and IFN-c are all known to induce the anagen-catagen transition
[29,41,43,44,45]. The expression of regulatory molecules is
controlled by upstream signals, such as those provided by the
NF-kB, Wnt/b-catenin, bone morphogenetic protein (BMP), and
Shh-Gli pathways [29,41,42]. On the basis of our findings, TAK1
should now be considered a part of the molecular machinery of the
anagen induction.
In the present study, we have shown that TAK1 deletion
severely delays the telogen-anagen transition, although it is not
completely suppressed, while deletion of TAK1 in anagen follicles
prematurely induces catagen and damages normal hair follicle
function. Thus, TAK1 activity is important, but not essential, for
anagen initiation and progression, yet is essential for the
maintenance of mature anagen follicles, with loss of TAK1
activity resulting in catagen induction. The next challenge is to
dissect the upstream and downstream signals of TAK1. Because
NF-kB is thought to be a downstream signal of TAK1 in hair
morphogenesis, and because strong NF-kB activity is detected in
the anagen matrix of pelage follicles of adult mice [37], NF-kBi sa
major candidate downstream signal of TAK1 in anagen induction.
Conversely, EdaR is a plausible candidate upstream signal of
TAK1 because EdaA1 and EdaR have already been shown to be
involved in hair follicle cycling [9,21,22].
After chemical, biological, or physical damage, hair follicles
develop abnormalities that are collectively called hair follicle
dystrophy [28]. Low follicular damage induces the ‘‘dystrophic
anagen’’ response. Severe follicular damage induces the ‘‘dystro-
phic catagen’’ response, characterized by an immediate anagen
termination. In Fig. 6, the hair follicle stage was defined as
‘‘dystrophic catagen’’. The development of ‘‘dystrophic catagen’’
indicates TAK1-deletion-induced follicular damage is compara-
tively higher and similar to those of high dose cyclophosphamide-
induced alopecia. These suggest that TAK1-deletion-induced
dystrophic catagen could be a model of chemotherapy-induced
alopecia.
Figure 6. Keratinocyte-specific TAK1 deletion causes a transition from anagen to dystrophic catagen in adolescent mice. (A)
Schedule of tamoxifen application. The hair cycle was synchronized to anagen phase by wax depilation. At 7 days after depilation, tamoxifen was
applied for 5 days. (B) Clinical appearance of the mice 2 weeks after depilation. (C) Histological analysis of the mice 2 weeks after depilation. (D)
Higher magnification of the tamoxifen-treated Map3k7
fl/flK14-Cre-ER
T2 mice in (C). Scale bar, 100 mm. (E) Dystrophic catagen was defined according to
a previous report [28]. Then, the rate (%) of a certain hair follicle stage per total hair follicles was calculated. Quantitative analyses confirmed that most
of the hair follicles in tamoxifen-treated Map3k7
fl/flK14-Cre-ER
T2 mice were in late dystrophic catagen, while those of controls were in anagen.
doi:10.1371/journal.pone.0011275.g006
Figure 7. Model for the signaling pathways involved in hair follicle development. In the development of primary hair placodes, TAK1 is
involved in the Edar/NF-kB pathway. In secondary hair placodes, NF-kB (TAK1)-independent pathways regulate hair placode development.
doi:10.1371/journal.pone.0011275.g007
TAK1 Regulates Hair Growth
PLoS ONE | www.plosone.org 8 June 2010 | Volume 5 | Issue 6 | e11275The evidence reported here, that TAK1, a critical mediator of
inflammation [1,30], is also involved in hair morphogenesis and
anagen induction.
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